XML 58 R46.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2021
Stock-Based Compensation [Abstract]  
Components of Stock-based Compensation Expense
The following table summarizes the components of stock-based compensation expense included in the consolidated statements of operations:
 
 
 
Three Months Ended March 31,
 
 
 
2021
   
2020
 
Stock-Based Compensation Expense:
           
Cost of revenue
 
$
71
   
$
45
 
Sales and marketing expense
   
505
     
94
 
Research and development expense
   
229
     
187
 
General and administrative expense
   
405
     
363
 
 
 
$
1,210
   
$
689
 
 
 
 
Three Months Ended March 31,
 
 
 
2021
   
2020
 
Stock-based compensation expense by type:
           
Employee stock purchase plan
 
$
1,085
   
$
431
 
Non-employee stock purchase plan
   
40
     
172
 
Subsidiary option grants
   
85
     
86
 
 
 
$
1,210
   
$
689
 
Assumptions Used to Determine Fair Value of Share Options Granted
The fair value of options granted to employee with a service period based condition is estimated on the grant date using the Black-Scholes valuation.

   
 Three months ended
March 31,
2021
Fair value of common share(1)
$48.25-51.07
Expected term in years(2)
 5.50-6.25
Volatility(3)
48.53%
Risk-free interest rate(4)
1.00%
Expected dividend(5)
0%

(1)
Equal to closing value on the grant date.
(2)
Expected term of share options is based on the average of the vesting period and the contractual term for each grant according to Staff Accounting Bulletin 110.
(3)
Volatility is calculated based on the historical volatility of ACM’s comparable companies in the period equal to the expected term of each grant.
(4)
Risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected term of the share options in effect at the time of grant.
(5)
Expected dividend is assumed to be 0% as ACM has no history or expectation of paying a dividend on its common stock.
Employee Share Option [Member]  
Stock-Based Compensation [Abstract]  
Summary of Share Option Activities
The following table summarizes the Company’s employee share option activities during the three-months ended March 31, 2021:
 
 
Number of
Option Share
 
Weighted
Average Grant
Date Fair Value
 
Weighted
Average
Exercise
Price
 
Weighted Average
Remaining
Contractual Term
Outstanding at December 31, 2020
3,191,411
 
$
5.13
 
$
12.73
 
7.13 years
Granted
106,400
   
50.67
   
111.98
   
Exercised
(255,582)
   
1.78
   
4.55
 
 
Forfeited/cancelled
(11,989)
   
27.45
   
62.58
 
 
Outstanding at March 31, 2021
3,030,240
   
6.93
 
$
16.70
 
7.22 years
Vested and exercisable at March 31, 2021
1,809,322
   
 
   
 
 
   
Employee Share Option [Member] | ACM Shanghai [Member]  
Stock-Based Compensation [Abstract]  
Summary of Share Option Activities
The following table summarizes the ACM Shanghai employee stock option activities during the three months ended March 31, 2021:
 
 
Number of
Option Shares in
ACM Shanghai
 
Weighted
Average Grant
Date Fair Value
 
Weighted
Average
Exercise
Price
 
Weighted Average
Remaining
Contractual Term
Outstanding at December 31, 2020
5,423,654
 
$
0.23
 
$
1.89
 
3.50 years
Granted
-
   
-
   
-
 
 
Exercised
-
   
-
   
-
 
 
Expired
-
   
-
   
-
 
 
Forfeited/cancelled
(46,154)
   
0.24
   
2.00
 
 
Outstanding at March 31, 2021
5,377,500
 
$
0.24
 
$
2.00
 
3.26 years
Vested and exercisable at March 31, 2021
-
   
 
   
 
 
   
Non-Employee Stock Option [Member]  
Stock-Based Compensation [Abstract]  
Summary of Share Option Activities
The following table summarizes the Company’s non-employee share option activities during the three months ended March 31, 2021:
 
 
Number of
Option Shares
 
Weighted
Average Grant
Date Fair Value
 
Weighted
Average
Exercise
Price
 
Weighted Average
Remaining
Contractual Term
Outstanding at December 31, 2020
836,038
 
$
1.02
 
$
3.07
 
4.92 years
Granted
-
   
-
   
-
   
Exercised
(54,358)
   
1.51
   
5.44
 
 
Expired
-
   
-
   
-
 
   
Forfeited/cancelled
(76)
   
0.30
   
0.75
 
   
Outstanding at March 31, 2021
781,604
 
$
0.99
 
$
2.91
 
4.64 years
Vested and exercisable at March 31, 2021
773,139